News
The U.S. Food and Drug Administration (FDA) takes action against GLP-1 drugs that have not received FDA approval.
The FDA will crack down on misleading direct-to-consumer (DTC) advertisements.
The FDA mentioned compounding pharmacies, including the affordable weight loss drug supplier Hims & Hers Health
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments